Background: Aim of this study was to evaluate the clinical impact of the culprit plaque features
| I N TR ODU C TI ON
Acute coronary syndromes (ACS) represent the most common reason for cardiac hospitalization in the western world, [1] with non-ST elevation myocardial infarction (NSTEMI) reported as the clinical presentation in approximately 70% of the .cases [2] .
ACS pathophysiology deeply differs from stable coronary artery disease, mainly due to the dissimilar features of underlying atherosclerotic disease, given that plaque destabilization is the usual cause of ACS. Even if unstable plaques responsible for ACS, usually defined "culprit lesions," are generally easily recognizable upon angiography, they often do not determine angiographically severe, but only mild, stenoses [3] [4] [5] [6] [7] . However, when evaluated at autopsy or with intracoronary imaging, these lesions show often pro-thrombotic patterns, like thin cap fibroatheromas (TCFA) and lipid rich-plaques with necrotic core, which are prone to rupture and thrombus formation [5] .
Absence of culprit plaque rupture (CPR) is very often observed in patients with ACS without severe angiographic stenoses. Mechanisms of destabilization leading to ACS include, among others, thrombus at the site of plaque erosion, intense vasoconstriction of epicardial arteries or coronary microcirculation dysfunction [6, 7] . In the last years, optical coherence tomography (OCT, 8) has emerged as the most accurate instrument for intracoronary evaluation and in-vivo plaque assessment. Due to its high resolution (approximately 10-20 mm) [8] [9] [10] [11] , it has been largely exploited in the evaluation and characterization of plaque features, especially in the acute setting. [12] Despite an increasing amount of evidence, [13] however, clinical and prognostic implications of the different culprit plaques' features in patients with ACS are still not well defined.
In this setting, aim of the present study was to evaluate, through the analysis of the data collected in the multicenter OCT-FORMIDABLE (OCT-Features Of moRphology, coMposItion anD instABility of culprit and pLaquE in ACS patients) registry, the clinical implications of the different culprit plaque features, visualized by OCT, in terms of rate of major acute cardiovascular events at follow-up and of therapy effectiveness in patients with ACS.
| M E TH ODS
The OCT-FORMIDABLE study is a multicenter registry retrospectively including all patients admitted for ACS who underwent OCT on culprit and not culprit lesions between January 2014 and October 2015 in 9 centers (See Supporting Information Appendix). Choice to perform OCT was left at the operator's discretion.
Patients with poor image quality, incomplete pull-back or missing data were excluded. Exclusion criteria were the absence of signed informed consent, patients who did not implant II generation drug eluting stent, age < 18 years old, pregnancy or shock, incomplete clinical data or loss at follow-up.
All patients provided informed consent; the study was approved by the local Ethics Committee and registered on ClincalTrial.gov (NCT02486861). Clinical and OCT data were collected in the register along with data on medications on admission and at hospital discharge.
For the index admission, diagnoses were attributed according to the available ESC guidelines as ST Segment Elevation Myocardial Infarction (STEMI), NSTEMI and unstable angina (UA) [1] .
Diabetes mellitus was defined according to the ADA criteria [14] [fasting blood glucose >126 mg/dL or treated diabetes mellitus (intake of a diabetic diet or oral hypoglycemic agents), hypercholesterolemia as the total cholesterol >200 mg/dL or treated hypercholesterolemia and hypertension as systolic blood pressure >140 mm Hg and/or diastolic blood pressure >90 mm Hg or treated hypertension. Patients were considered on optimal medical therapy (OMT) if discharged on aspirin, ACE-inhibitors/Angiotensin Receptor Blockers, ß-blockers and prasugrel/ticagrelor.
| Invasive treatment and clinical data collection
All STEMI patients were treated with aspirin (300 mg) and clopidogrel 
| OCT procedure
A 0.014-inch guidewire was placed distally in the target vessel and an intracoronary injection of 200 mg of nitroglycerin was performed. Frequency domain OCT (FD-OCT) images were acquired by a commercially available system, which was advanced to the culprit lesion. In case of STEMI, OCT was performed after vessel reopening with thrombus aspiration if necessary. During image acquisition, coronary blood flow was replaced by continuous flushing of contrast media directly from the guiding catheter at a rate of 3-4 mL/s with a power injector to create a virtually blood-free environment. Culprit lesion was identified by means of angiography, electrocardiographic ST-segment alterations, and/or regional wall motion abnormalities on echocardiographic assessment. In dubious cases, results of intracoronary imaging with OCT were used to define the culprit lesion.
| OCT image analysis
Plaque rupture was defined as the presence of fibrous cap discontinuity leading to a communication between the inner (necrotic) core of the plaque and the lumen. Rupture length was considered as the longest discontinuity interval "intima to intima" in a ruptured plaque.
Plaques without evidence of discontinuity, rupture, erosion or thrombus were labeled as intact fibrous cap plaques (IFC). TCFA was defined by the presence of a cap thickness < 65 nm. Presence of TCFA at rupture site was recorded.
Necrotic core was considered as a signal-poor region within an atherosclerotic plaque, with poorly delineated borders and little or no OCT signal backscattering, within a lesion that is covered by a fibrous cap, macrophage infiltration as signal-rich, distinct, or confluent punctate regions that exceed the intensity of background speckle noise. 
| Clinical follow-up and, end-points definitions
Clinical follow-up was conducted through clinical visits or phone calls at 6 months intervals. 
| Sample size calculation
The recent paper of Niccoli et al. [16] showed a percentage of plaque rupture of 60% in ACS. According to the paper of Pedruzzi et al. [17] , at least 100 patients are needed to evaluate independent predictive power of clinical presentation (STEMI vs NSTEMI vs UA), diabetes mellitus, previous use of aspirin, of statin and age. [18] in eight multivariate models due to the low number of events. Kaplan-Maier survival analysis comparing categorical variables by log-rank test was performed. Sensitivity analysis was performed for the presence of CPR on therapy efficacy, p interaction between subgroups was addressed with ANOVA test. Intraobserver and interobserver differences were investigated with kappa measure of agreement. A two-sided P value <.05 was considered statistically significant; all analyzes were performed with SPSS 21.0 (IBM, Armonk, NY).
| Statistical analysis

| RE S U L TS
| Overall population
This sub-analysis of the OCT-FORMIDABLE registry included 209 patients (see Supporting Information Appendix Figure S1 ). Baseline clinical and angiographic characteristics are shown in Table 1 . Mean age was 60.1 6 12.9 years, 19.1% of the patients were of female gender, 51.7% hypertensive, 13.9% with insulin dependent diabetes mellitus. Main clinical presentation was ST-elevation myocardial infarction (STEMI, 55%) and the left anterior descending was the most frequent culprit artery (55%). Thrombus aspiration was performed in 63% of the patients with STEMI. At discharge, 99% of the patients were prescribed a dual antiplatelet therapy (DAPT), 88.5% beta-blockers and 98.6% statins. During follow-up (12.6 6 14.5 months), 11% of the patients experienced MACEs, mainly re-ACS (7.2%), while 3.5% of patients experienced TVR and 2.3% died because of cardiac causes.
| Optical coherence tomography findings
Kappa measures of agreement for interobserver variability were 0.91 (p5 0.0001) for plaque rupture, 0.96 (P 5 .0001) for TCFA, 0.86 (P 5 .0001) for necrotic core with macrophage infiltration (NCMI) (see Supporting Information Table S1 ).
OCT data are shown in Table 2 and Supporting Information Table   S2 . Plaque rupture was present in 71.8% of the analyzed plaques, mean rupture length was 7.1 6 8 mm. Mean fibrous cap thickness was 139.7 6 90.7 lm, while TCFA was present in the 66.5% of the patients (plaque rupture or IFC). Culprit plaques were characterized in the 85.6% of the cases by lipid components, 45.9% were fibro-calcific, 31.6% presented NCMI.
| Predictors of MACEs in the overall population
At Kaplan-Mayer analysis, patients with CPR (log-rank P 5 .02, HR 2.9, 1.1-7.8, P 5 .03, Figure 1 Panel A) or NCMI (log-rank P < .01, HR 4.5, 2.1-9.8, P < .01, Figure 1 Table S3 ).
At multivariate regression analysis, plaque rupture (HR 3.7, 1.4-9.8, P < .01) and NCMI (HR 3.3, 1.6-6.6, P < .01) were confirmed as independent predictors for MACEs, while DAPT with prasugrel/ticagrelor at discharge remained protective (HR 0.2, 0.1-0.6, P < .01). Clinical cardiovascular risk factors, such as smoke, hypertension and diabetes, are well know players which impact on atherosclerosis burden [19] [20] [21] , determining coronary artery stenosis and angina.
However, just a limited number of plaques undergo destabilization and evolve in ACS. Plaque rupture is the most common substrate of ACS, as suggested both by pathological studies and more recently OCT studies [11] . Even if its pathophysiology is still unclear, the formation of TCA, which is mainly driven by the gradual loss of smooth muscular cells and collagen through macrophage degradation from the fibrous cap, can be assumed, as shown by Virmani et al. [3] , as one of the most important markers of plaques prone to rupture.
Previous studies, in particular by Niccoli et al. [16] , have demonstrated that patients with ACS presenting with CPR by OCT have a An important point to underline is that the higher MACE rate observed in relation with CPR and NCMI at the culprit site was driven by re-ACS and not only by target lesion revascularization, as could be expected. A possible explanation for this finding is that both CPR and NCMI are markers of diffuse coronary artery remodeling, characterized by innate immune activation with activated monocytes, polymorph nuclear neutrophils, eosinophils and mast cells, not only at the site of plaque rupture, but also in the whole coronary tree [24] . Moreover, OCT findings in this setting may potentially help to guide therapeutic decisions, as a more aggressive anti-platelet regimen has been shown to be particularly effective in patients with CPR. However, further prospective data are needed to corroborate these points.
| C ONC LUSI ON
The results of this large, multicenter registry including patients with ACS undergoing plaque morphology evaluation with OCT, the detection of CPR or NCMI independently predicted a higher rate of MACE at follow-up. OCT may also be helpful to guide the therapy of these patients, as the detection of CPR resulted to benefit mostly from an intensive antiplatelet therapy with Prasugrel or Ticagrelor. 
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